Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KDNY | ELVN | BCRX | ||
| Company | Chinook Therapeutics Inc | Enliven Therapeutics Inc | Biocryst Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.31 | 51.49 | 9.81 | ||
| High | 40.51 | 52.39 | 10.17 | ||
| Low | 40.30 | 50.35 | 9.68 | ||
| Latest | 40.39 | 50.75 | 10.00 | ||
| Change | +0.09 | -0.10 | +0.45 | ||
| % Change | +0.22% | -0.20% | +4.71% | ||
| Volume | 4,924,900 | 2,016,900 | 7,719,700 | ||
| 20-Day Average Volume | 2,629,690 | 2,528,080 | 5,944,475 | ||
| Previous Close | 40.30 | 50.85 | 9.55 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.61 | 42.65 | 8.97 | ||
| 20-Day Raw Stochastic | 92.73% | 91.34% | 67.36% | ||
| 20-Day Relative Strength | 77.95 | 65.33 | 61.55 | ||
| Weighted Alpha | +55.60 | +62.85 | +24.30 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.25% since 08/03/23 | +4.42% since 06/23/26 | +7.41% since 06/23/26 | ||
| Low | 40.25 on 08/04/23 | 46.81 on 06/24/26 | 9.39 on 06/24/26 | ||
| High | 40.51 on 08/10/23 | 52.39 on 06/30/26 | 10.94 on 06/25/26 | ||
| 1-Month | |||||
| %Chg | +3.30% since 07/10/23 | +28.25% since 05/29/26 | +12.23% since 05/29/26 | ||
| Low | 38.86 on 07/21/23 | 33.45 on 06/08/26 | 8.06 on 06/03/26 | ||
| High | 40.51 on 08/10/23 | 52.39 on 06/30/26 | 10.94 on 06/25/26 | ||
| 3-Month | |||||
| %Chg | +74.62% since 05/10/23 | +38.70% since 03/30/26 | +5.82% since 03/30/26 | ||
| Low | 19.20 on 05/16/23 | 33.45 on 06/08/26 | 7.78 on 05/06/26 | ||
| High | 40.51 on 08/10/23 | 52.39 on 06/30/26 | 10.94 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +67.39% since 02/10/23 | +226.37% since 12/30/25 | +30.55% since 12/30/25 | ||
| Low | 18.34 on 05/02/23 | 14.78 on 01/06/26 | 6.23 on 02/05/26 | ||
| High | 40.51 on 08/10/23 | 52.39 on 06/30/26 | 10.94 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,900,204 | 3,090,929 | 2,541,630 | ||
| Shares Outstanding, K | 71,805 | 60,905 | 254,163 | ||
| Annual Sales | 6,130,000 | 0 | 874,840,000 | ||
| Annual Net Income | -187,870,000 | -103,690,000 | 263,860,000 | ||
| Last Quarter Sales | 1,830,000 | 0 | 156,410,000 | ||
| Last Quarter Net Income | -60,180,000 | -23,630,000 | -721,810,000 | ||
| 60-Month Beta | 0.34 | 0.29 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 08/07/23 | -0.38 on 05/07/26 | -0.03 on 05/06/26 | ||
| Earnings Date | 11/09/23 | 08/12/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 7.35 | ||